This article is more than 5 years old. Information may no longer be current.

STAAR Surgical gains regulatory approval for IOL, ICL

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — STAAR Surgical received CE mark approval for a hydrophobic acrylic IOL, in addition to receiving approval to market an implantable Collamer lens in Brazil, the company announced in a press release.

The KS-SP preloaded single-piece hydrophobic acrylic IOL is inserted into the eye through a 2.8-mm incision, and the company's proprietary injector system uses an independently sourced lens to eliminate glistening, the release said.

STAAR is planning a limited market launch for the IOL in July, with a full market launch during the fourth quarter.

The Visian implantable Collamer lens V4 design will be launched in Brazil during the third quarter. The company owns the ICL registration in Brazil and will continue to move forward to the upgraded V4c design, according to the release.